The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.
Open accessAbstract
Activated components of the complement system are potent mediators of inflammation that may play an important role in numerous disease states. For example, they have been implicated in the pathogenesis of inflammatory joint diseases including rheumatoid arthritis (RA). To target complement activation in immune-mediated joint inflammation, we have utilized monoclonal antibodies (mAbs) that inhibit the complement cascade at C5, blocking the generation of the major chemotactic and proinflammatory factors C5a and C5b-9. In this study, we demonstrate the efficacy of a mAb specific for murine C5 in the treatment of collagen-induced arthritis, an animal model for RA. We show that systemic administration of the anti-C5 mAb effectively inhibits terminal complement activation in vivo and prevents the onset of arthritis in immunized animals. Most important, anti-C5 mAb treatment is also highly effective in ameliorating established disease. These results demonstrate a critical role for activated terminal complement components not only in the induction but also in the progression of collagen-induced arthritis and suggest that C5 may be an attractive therapeutic target in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wooley, P. H., Luthra, H. S., Stuart, J. M., & David, C. S. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.688 · Cited by 687
C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor
Gerard, C., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 416
Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
Ranges, G. E., Sriram, S., & Cooper, S. M. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.3.1105 · Cited by 365
Stuart, J. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.199 · Cited by 186
Development of C5a receptor antagonists. Differential loss of functional responses.
Konteatis, Z. D., Siciliano, S. J., Riper, G. V., Molineaux, C. J., Pandya, S., Fischer, P. A., Rosen, H., Mumford, R. A., & Springer, M. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4200 · Cited by 151
Membrane signaling by complement C5b-9, the membrane attack complex
Nicholson-Weller, A., & Halperin, J. A. (1993) · Immunologic Research · doi:10.1007/bf02918256 · Cited by 149
Brodeur, J. P., Ruddy, S., Schwartz, L. B., & Moxley, G. F. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341209 · Cited by 133
Frei, Y., Lambris, J. D., & Stockinger, B. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90022-3 · Cited by 90
Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies
Würzner, R., Schulze, M., Happe, L., Franzke, A., BIEBER, F. A., Oppermann, M., & Götze, O. (2017) · Complement and Inflammation · doi:10.1159/000463204 · Cited by 90
Högåsen, K., Mollnes, T. E., Harboe, M., Götze, O., Hammer, H. B., & Oppermann, M. (1995) · PubMed · Cited by 82
Barton, P. A., & Warren, J. S. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1474-1481.1993 · Cited by 64
Mattsson, E., Rollof, J., Verhoef, J., van Dijk, H., & Fleer, A. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3837-3843.1994 · Cited by 64
Rothstein, J. L., Lint, T. F., & Schreiber, H. W. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.6.2007 · Cited by 48
Immune Mediated Cartilage Destruction
Jasin, H. E. (1988) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748809102960 · Cited by 14
Cited by
TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
Plenge, R. M., Seielstad, M., Padyukov, L., Lee, A. T., Remmers, E. F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies, L. R. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073491 · Cited by 823
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Arthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Wipke, B. T., & Allen, P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1601 · Cited by 585
Metadata
- Authors
- Wang, Y., Rollins, S. A., Madri, J. A., & Matis, L. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-09-12
- Volume
- 92
- Issue
- 19
- Pages
- 8955-8959
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2056824071
- Cited by
- 360
- References
- 14
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.